Cronos Group Inc. shares advanced to a 52-week high of $3.44 on Tuesday, extending a broader upward trend that has delivered a 31.08% gain over the past 12 months.
The Toronto-based cannabis company’s stock traded near the intraday peak at $3.43, up 3.63% on the session, according to real-time data. The company’s market capitalization has reached $1.25 billion, while its year-to-date performance stands at 25.86%.
The latest rally follows the release of Cronos Group’s second-quarter results, which exceeded analyst expectations across key financial metrics. Revenue totaled $53 million, surpassing the $44.73 million forecast. Adjusted earnings per share came in at $0.09, well above the anticipated $0.01. Gross profit set a record at $28.5 million, while adjusted EBITDA climbed to $13.1 million.
Cash, cash equivalents and investments stood at $827 million at quarter-end, supported by $24 million in operating cash flow generated during the period. The company also executed $60 million in stock buybacks in Q2.
Cronos Group highlighted strong performance across its core markets in Canada and Israel, as well as continued growth in international operations. InvestingPro analysis, however, flagged the stock as overvalued relative to its fair value estimate.
Shares of Cronos Group, listed under the ticker CRON on Nasdaq, have gained momentum in recent months amid improved sector sentiment and company-specific catalysts.
